Commercial
Indication expansion & launch sequence strategy
Project Management
Competitive defense strategies (including biosimilars)
Consulting
Global pricing and market access
In-licensing / asset acquisition valuations
Business Development
pricing & market access evidence assessment
Product lifecycle and loss of exclusivity strategies
New product and portfolio commercial strategies